TSX

Cannara Biotech Inc.

LOVE.TO•Healthcare•Drug Manufacturers - Specialty & Generic
Current Price
$2.04
Today's Change
-2.39%
Market Cap
$201.52M
Volume
24.19K

Financials from Cannara Biotech Inc.'s company filings · Latest period: 2026-Q3 (ended )

Latest results: Q3 2026

See every quarter

Revenue

$31.83M

+16.4% vs a year earlier

Net income

$4.84M

Operating cash flow

$5.68M

Cash

$21.81M

💡 Quick Take

Cannara Biotech Inc. specializes in the indoor cultivation, processing, and sale of cannabis and cannabis-derived products in Canada. The company exhibits strong financial health with a gross margin of 47.2% and an EBITDA margin of 28.2%, indicating efficient operations. However, its return on equity (ROE) of 3.8% and market cap of $201.52M suggest potential concerns regarding profitability and valuation relative to its margins. Additionally, while the current ratio of 3.00 reflects solid liquidity, the stock's recent decline of 2.39% may signal market apprehension.

Based on 27 data points⚠️Not financial advice

📊 Key Metrics

52 Week High$2.37
52 Week Low$1.08
Avg Volume41.32K
Beta0.33
Shares Outstanding98.78M

🔥 Valuation

Market Cap$201.52M
Enterprise Value$221.65M
P/E Ratio17.66
EV/EBITDA6.78x
Dividend Yield0.00%

Loading financial metrics...

🚩 Red Flags

🟡

Margin Pressure

Gross profit margin decreased from 44.6% to 38.5% compared to last year.

🌟 Opportunities

💪

Strong revenue growth of 15.4% YoY indicates solid business momentum.

🚀

Operating cash flow of $18.9M exceeds net income by 74%, indicating high-quality earnings with strong cash conversion.

💪

Strong cash flow conversion with 16.0% of revenue converting to operating cash.

🚀

Excellent liquidity with current ratio of 3.0x ensures operational stability.

💪

Strong free cash flow margin of 16.0% provides substantial resources for dividends, buybacks, or reinvestment.

Want the Complete Picture?

Valuation, risk assessment, competitive positioning, and key insights — all in one report.

Free account:3 reports remaining

Recent Developments

Loading news...

Similar companies

Other Drug Manufacturers - Specialty & Generic companies of a similar size